Your browser doesn't support javascript.
loading
Relationship of Hematological Profiles with the Serum Complement System in Patients with Systemic Lupus Erythematosus.
Fernández-Cladera, Yolanda; García-González, María; Hernández-Díaz, Marta; Gómez-Bernal, Fuensanta; Quevedo-Abeledo, Juan C; González-Rivero, Agustín F; de Vera-González, Antonia; Gómez-Moreno, Cristina; González-Gay, Miguel Á; Ferraz-Amaro, Iván.
Afiliação
  • Fernández-Cladera Y; Division of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
  • García-González M; Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
  • Hernández-Díaz M; Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
  • Gómez-Bernal F; Division of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
  • Quevedo-Abeledo JC; Division of Rheumatology, Hospital Doctor Negrín, 35010 Las Palmas de Gran Canaria, Spain.
  • González-Rivero AF; Division of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
  • de Vera-González A; Division of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
  • Gómez-Moreno C; School of Nursing, Fundación Jiménez Díaz, Autonomous University of Madrid, 28040 Madrid, Spain.
  • González-Gay MÁ; Division of Rheumatology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, 28040 Madrid, Spain.
  • Ferraz-Amaro I; Department of Internal Medicine, University of Cantabria, 39005 Santander, Spain.
Biomedicines ; 12(5)2024 Apr 27.
Article em En | MEDLINE | ID: mdl-38790929
ABSTRACT
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder identified by hematological abnormalities including anemia, leukopenia, and thrombocytopenia. Complement system disturbance is implicated in the pathogenesis of SLE. In this work, we aim to study how a full assessment of the complement system, which includes the evaluation of its three pathways, relates to blood cell counts in a population of patients with SLE. New-generation functional assays of the classical, alternative, and lectin pathways of the complement system were conducted in 284 patients with SLE. Additionally, serum levels of inactive molecules (C1q, C2, C3, C4, factor D) and activated molecules (C3a), as well as regulators (C1-inhibitor and factor H), were evaluated. Complete blood cell counts were analyzed. Multivariable linear regression analysis was performed to study the relationship of hematological profiles with this full characterization of the complement system. After multivariable adjustments that included age, sex, SLICC-DI (damage), and SLEDAI (activity) scores, as well as the use of aspirin, prednisone, methotrexate, azathioprine, and mycophenolate mofetil, several relationships were observed between the C pathways and the individual products and blood cells profile. Lower values of C1q and C2 were associated with lower hemoglobin levels. Lower leukocyte counts showed significantly lower values of C4, C1 inhibitor, C3, factor D, and alternative pathway functional levels. Neutrophil counts showed significant negative relationships only with the alternative pathway and C1-inh. In the case of lymphocytes, associations were found, especially with functional tests of the classical and alternative pathways, as well as with C2, C4, C3, and C3a. On the contrary, for platelets, significance was only observed, after multivariable adjustment, with lower C2 concentrations. In conclusion, the serum complement system and hematological profile in SLE are independently linked, after adjustment for disease activity and damage. These relationships are basically negative and are predominantly found in lymphocytes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article